← FDA Drug Approvals (Drugs@FDA)

TAFLUPROST

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: MICRO LABS · Approved 2019-08-19

Drug application

FDA Application #

ANDA209051

Application type

Abbreviated New Drug Application (Generic)

Brand name

TAFLUPROST

Generic name

TAFLUPROST OPTHALMIC

Active ingredients

TAFLUPROST

Dosage form

SOLUTION/DROPS

Route

OPHTHALMIC

Marketing status

Prescription

Sponsor

MICRO LABS

Manufacturer

Micro Labs Limited

First approval

2019-08-19

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown